Navigation Links
PAREXEL Reaches Agreement To Acquire ClinPhone
Date:6/13/2008

f PAREXEL International, said: "As the use of technology has expanded in the conduct of clinical research, PAREXEL has been a leader in helping to advance the convergence of services and technology in the market. Biopharmaceutical companies have increasingly demanded PAREXEL technology solutions and expertise to support the full range of clinical development activities while improving the speed and efficiency of clinical programs. We anticipate that this acquisition will bring the many technologies and capabilities of ClinPhone into the PAREXEL organization and advance our position as a clinical technology leader."

He continued, "The combination of complementary capabilities of PAREXEL and ClinPhone would provide clients with a more comprehensive suite of clinical information technologies. As the market embraces a total eClinical solution we believe clients will realize even more significant process efficiencies, greater visibility across studies, improvements in data quality, and accelerated decision-making."

It is currently envisaged that the acquisition will be implemented by way of a scheme of arrangement provided for under English company law and conditional on, among other things, its approval by a majority in number representing three quarters in value of the members of ClinPhone who vote at the meeting, and any required antitrust approval by the regulatory authorities in the United States and the United Kingdom.

PAREXEL expects that the acquisition will be dilutive to earnings in its financial year ending 30 June 2009. Excluding amortization of intangibles, the acquisition will be accretive to earnings in that same period. The extent of the dilutive impact of the acquisition will not be known until closing of the transaction, at which time PAREXEL will have had the opportunity to review the results of the intangibles valuations which are in the process of being compiled by an external third party valuation firm. Upon closing of the trans
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. PAREXEL International to Present at Goldman Sachs 29th Annual Global Healthcare Conference
2. PAREXEL Product Development and Regulatory Experts to Attend the 2008 BIO International Convention
3. PAREXEL Appoints Leading Biostatistician Dr. Imogene Grimes to Vice President of Data Sciences Strategic Services
4. PAREXEL Reports Third Quarter Fiscal Year 2008 Financial Results
5. PAREXEL Experts to Offer Insights Into Outsourcing Best Practices at 17th Annual Partnerships with CROs Conference
6. PAREXEL Appoints Leading Central Nervous System Experts to Its Global Clinical Pharmacology Business
7. PAREXEL International Expands Relationship with Synchron Research in India and Divests Bioanalytical Laboratory in France
8. PAREXEL Announces Date of Third Quarter Fiscal Year 2008 Earnings Release and Conference Call
9. PAREXEL Appoints Leading Biopharmaceutical Marketing Expert Jacque Fisher to Medical Communications Services Executive Team
10. PAREXEL International to Present at Lehman Brothers 11th Annual Global Healthcare Conference
11. PAREXEL International to Present at Raymond James 29th Annual Institutional Investors Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... ... 2015 , ... Apex Therapeutics announced today that company CEO, David Broecker provided ... , The presentation took place on Tuesday, June 16 and provided an update on ... for the treatment of pancreatic cancer. A copy of the company overview can ...
(Date:6/30/2015)... /PRNewswire/ - Resverlogix Corp. ("Resverlogix") (TSX:RVX) announced today ... have approved the resolutions relating to: (i) a ... units at a price of $2.67 per unit ... of one common share and 0.075358 common share ... million; and (ii) the amendment to Resverlogix,s articles ...
(Date:6/30/2015)... ... June 30, 2015 , ... uBiome ... new insights on mechanics of fecal microbiota transplantation in C. difficile patients. , ... microbiome of patients undergoing fecal microbiota transplantation (FMT) as a treatment for Clostridium ...
(Date:6/30/2015)... DIEGO , June 30, 2015  The ... Education in Biosciences (CCE/Bio) and UC San Diego ... fermentation, to be held Aug.  12 – 14, ... ).  This three-day workshop provides an intense exposure ... industrial biotechnology, and is well-suited to biologists, process ...
Breaking Biology Technology:Apex Therapeutics Presented Company Overview at This Year’s BIO International Convention in Philadelphia, PA 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 3uBiome and OpenBiome Partner for Microbiome Study in FMT Patients 2uBiome and OpenBiome Partner for Microbiome Study in FMT Patients 3UC San Diego Extension to Offer Third Annual Microbial Fermentation Workshop 2
... National Healthcare Decisions Day, your choice in times of ... Inc .( www.usoncology.com ), supporting the ... providers, payers and manufacturers to advance cancer care in ... National Healthcare Decisions Day ( ...
... Cynvec LLC, a privately held,biotechnology company focused on developing ... sindbis viral vector, today announced,that Frank Stonebanks, President and ... Meeting, Bioscience Industry Showcase on Monday, April,20, 2009 at ... Marriott Marquis,Hotel, Belasco Room, in New York City. , ...
... 2009 Medical Design Excellence Award(R)MINNEAPOLIS, April 13 ... and manufacturer announced today the InterFuse(R) Interbody Fusion ... Award (MDEA) recipient. "Vertebral Technologies is pleased ... this prestigious award. VTI,s engineering team designed an ...
Cached Biology Technology:US Oncology Encourages Your Right to Decide 2US Oncology Encourages Your Right to Decide 3Vertebral Technologies Receives Award for InterFuse(R) Interbody Fusion System 2
(Date:6/24/2015)... Biometry authentication provider KeyLemon today announced ... one face in. Logo - ... in, entering the expanding biometric authentication market in ... answer to the password problem. With advanced face ... KeyLemon, one face in allows users to securely ...
(Date:6/23/2015)... , June 23, 2015   Valencell, ... announced the results of a recent study that ... on the wrist during activity. In a study ... was compared along with the Apple Watch against ... measuring heart rate during activity. The study demonstrated ...
(Date:6/18/2015)... 18, 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... the growing mobile commerce market announces that its Wocket® smart ... "Money on the Mark", scheduled to air on WABC Radio ... 20 th . The broadcast air- time ... to 8:00pm EST. NXT-ID, Inc.,s CEO Gino Pereira ...
Breaking Biology News(10 mins):KeyLemon Announces Partnership With Biometric Password Solution onefacein 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3
... Cold, published in 1970, was a bestseller and led many ... cold prevention and treatment. But an article in this month's ... this topic, suggests that the public's enthusiasm for the vitamin ... National University, Canberra, and Harri Hemilä of the University of ...
... North American stilt-legged horses have found a new place ... in the open access journal PLoS Biology. In the ... DNA to argue that the Hippidion genus is younger ... American endemics, not Asian emigres. Their analysis has also ...
... no picture available yet, but there's a recent wiki article ... Is it a squirrel? A rat? A Guinea pig? Try none ... Asia have discovered a long-whiskered rodent with stubby legs and a ... Or a rat. Because it's actually more like a guinea pig ...
Cached Biology News:Does vitamin C help prevent or treat the common cold? Maybe not, after all. 2Ancient DNA helps clarify the origins of two extinct New World horse species 2Scientists discover odd-ball rodent 2
Anti-Chicken IgY, (IgG) F(ab')2 Fragment Specific....
Presenilin 2 Immunogen: Synthetic peptide corresponding to residues 31-47 of human Presenilin 2. Storage: -20 C, Avoid Freeze/Thaw Cycles...
SHP-2 Antibody...
200 μg per ml DNA in 10 SSPE, 2 Denhardt's...
Biology Products: